ML18130A890
ML18130A890 | |
Person / Time | |
---|---|
Site: | 03038705 |
Issue date: | 05/09/2018 |
From: | Jackie Cook NRC Region 4 |
To: | Harmon J Alaska Cancer Treatment Center |
References | |
602569 | |
Download: ML18130A890 (2) | |
See also: IR 05000351/2023001
Text
UNrfED STATES
NUCLEAR REGULATORY COMMISSION
REGION IV
1600 EAST LAMAR BlVD
ARLINGTON, TEXAS 76011-4511
EMAI L
Name: Joseph Harmon, Ph.D., DABR License: 50-35123-01
Organ*zation: Alaska Cancer Treatment Center Docket: 030-38705
Phone: 907-276-2803 Control: 602569
E-mail Address: fharmon@akmed.com
From: Jacqueline D. Cook
Date: May 9, 2018
Subject: Letter dated February 22, 2018 for License Amendment
Pages: 2
Dr. Harmon:
Per your letter dated February 22, 2018, the item on the next page is a deficiency which requires
your response. Please respond to this e-mail by Wednesday, May 23, 2018. Our fax number
is (817) 200-1263. Please provide a response in a signed and dated letter in pdf format
when responding via email. My email address is Jackie.Cook@nrc.gov. When responding to
this e-mail, please include the license, docket, and control numbers located at the top of this
page.
Thanking you in advance for your cooperation , assistance, and prompt response in this matter.
IRA/
Jacqueline D. Cook
Senior Health Physicist
PUBLIC
C Jmmedlate Release
"Nonnal Release
NON-PUBLIC
C A.3 Sensitive-Security Related
0 A.7 Sensitive Internal
O Other:
Reviewer: .'?Cpl~~.-.-D-a-..~
J . Harmon, Ph .D. -2-
1. Please note in your amendment request dated February 22, 20 *t 8, you stated that your
request is based on information contained within NRC Regulatory Issue Summary 2008-
31 , Licensing Requirements for Sentinel Lymph Node Biopsy.
Please note that this guidance has been superseded by Low Activity Radioactive Seeds
Used for Localization of Non-Palpable Lesions and Lymph Nodes Licensing Guidance,
dated October 7, 2016, Revision 1
(https://www.nrc.gov/docs/ML 1619/ML 16197 A568 .pdf) and is now licensed under
10 CFR 35. 1000.
Please resubmit your amendment request using the updated licensing guidance dated
October 7, 2016, Revision 1.